FdaApplication
ANDA 206091
Identifiers
- fda_app_no: ANDA206091
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2023-10-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION;INJECTION |
| ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION;INJECTION |
2 products